Abstract

Dear Editor,
Burning mouth syndrome (BMS) has evolved from traditional terms such as “glossodynia” and “stomatodynia,” which did not necessarily imply a burning quality. Although the International Classification of Headache Disorders, 3rd Edition (ICHD-3) and the International Classification of Orofacial Pain (ICOP) both describe BMS as a chronic intraoral burning or dysaesthetic sensation, the official diagnostic criteria in ICHD-3 still emphasize “burning” as the defining term.1 We contend that patients with similar clinical profiles—normal oral mucosa, persistent daily oral discomfort or pain, and characteristic fluctuations—often report other dysaesthetic descriptors (e.g., tingling, rasping) rather than “burning.”
Historical context and our clinical data
Historically, Silverman et al. introduced the term “burning mouth syndrome” in 1967, although “glossodynia” and “stomatodynia” were used in earlier literature to describe tongue or oral mucosal pain without a strict focus on burning. According to the 1994 International Association for the Study of Pain (IASP) Classification of Chronic Pain, glossodynia, burning tongue, and oral dysesthesia (OD) are regarded as the same clinical entity. In recent years, an alternative perspective emphasizing dysaesthesia over burning sensation has been proposed.2,3 Farag et al. contend that “BMS is just one of the conditions under the umbrella of OD.”3 Over the past 17 years, we have examined more than 5,700 patients with “OD.” While our data are based on large-scale but uncontrolled clinical observations, we have consistently found that many patients who would otherwise fit the clinical pattern of BMS do not necessarily use “burning” to describe their pain.4 They may refer to it as stinging, tingling, or throbbing, suggesting a broader array of dysaesthetic experiences.
Broader pain descriptors vs. non-painful symptoms
We are not suggesting that non-painful symptoms such as dryness or taste alterations be added to the mandatory criteria for BMS. Although these symptoms often coexist with oral dysesthesias and may help phenotype patients, studies like Kolkka et al. indicate these features can also occur in age-matched controls.5 Our key argument concerns the pain descriptors: “burning” alone may exclude patients who use alternative terms to describe dysaesthetic oral pain.
Proposed refinement to future criteria
Both ICHD-3 and ICOP note that BMS can manifest as a “burning or dysaesthetic sensation.” However, only “burning” is explicitly listed in the ICHD-3 diagnostic criteria. We advocate refining this language to “burning or dysaesthetic quality of pain,” thus preserving the framework of BMS as a chronic oral pain condition while encompassing broader dysaesthetic expressions commonly seen in clinical practice. This clarification would align better with ICOP, which recognizes a broader spectrum of sensory aberrations in BMS. By doing so, researchers and clinicians could more accurately categorize patients and potentially enhance our understanding of common underlying mechanisms.
Conclusion
BMS has historically and clinically encompassed a range of pain descriptions beyond “burning.” Integrating “dysaesthetic” explicitly into the ICHD-3 diagnostic criteria would prevent the inadvertent exclusion of patients whose intraoral pain is clinically consistent with BMS yet describe with different sensory terms. Such a revision could facilitate better research, improved diagnostic precision, and more personalized approaches to treatment. We look forward to potential updates in future editions (e.g., ICHD-4) that might incorporate these perspectives.
Footnotes
Acknowledgements
During the preparation of this manuscript, we used ChatGPT o1 pro mode (OpenAI) to translate the text from Japanese to English, as well as to rephrase and conduct a thorough grammar check. This use of AI was solely for improving the clarity and comprehensibility of the manuscript, and the authors take full responsibility for its final content.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethics or Institutional Review Board Approval
All participants provided written informed consent prior to enrollment, and the study protocol was reviewed and approved by the hospital’s ethics committee (D2013-005-04).
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by KAKENHI from the Japanese Society for the Promotion of Science (JSPS), grant number 22K10141 to AT.
